|
|
China Shenghuo Completes Restatement; Issues Q3 Report
publication date: Nov 21, 2008
China Shenghuo Pharmaceutical Holdings (昆明圣火药业(集团)有限公司) released its Q3 financial report and also announced that it has completed restatement of financial results for 2007 and the first two quarters of 2008. Most notable was the restatement in 2007’s net income, which dropped by a very significant $2.3 million, taking it down to $1.7 million. In Q3, revenues climbed 73%, but net income dropped. More details... Stock Symbol: (AMEX: KUN)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|